| Citation: |
YANG Jia, CHEN Min, LI Minghua, QIN Jingru, WANG Zhongqi. Effects of Sanguinarine on Invasion, Migration and Wnt/β-catenin Signaling Pathway of Lung Adenocarcinoma Cells[J]. Cancer Research on Prevention and Treatment, 2019, 46(12): 1057-1061. DOI: 10.3971/j.issn.1000-8578.2019.18.1576
|
To investigate the effect of sanguinarine on the invasion and migration of lung adenocarcinoma cells and its preliminary molecular mechanism.
MTT assay was used to observe the proliferative capacity of A549 and H1975 cells. Wound healing and Transwell assays were performed to determine the invasion and migration abilities of A549 and H1975 cells, respectively. RT-qPCR and Western blot were used to detect the mRNA and protein expression of core genes in Wnt/β-catenin signaling pathway.
Compared with the control group, sanguinarine(1-10μmol/L) could inhibit the activity of human lung adenocarcinoma cells in a concentration- and time- dependent manner (P < 0.05); the migration and invasion abilities of A549 and H1975 cells were significantly weakened by 1μmol/L sanguinarine after 48 h (P < 0.01); sanguinarine (1, 2.5, 5μmol/L) could significantly down-regulate the protein expression of β-catenin, phosphorylated GSK3β and DVL2 in Wnt/β-catenin pathway, thereby inhibiting the mRNA levels of TCF/LEF and CyclinD1, in a concentration-dependent manner (P < 0.05).
Sanguinarine may inhibit the migration and invasion of human lung adenocarcinoma cells by down-regulating the Wnt/β-catenin signaling pathway.
| [1] |
Barlesi F, Vansteenkiste J, Spigel D, et al. Avelumab versus docetaxel in patients with platinum-treated advanced non-small-cell lung cancer (JAVELIN Lung 200): an open-label, randomised, phase 3 study[J]. Lancet Oncol, 2018, 19(11): 1468-1479. doi: 10.1016/S1470-2045(18)30673-9
|
| [2] |
Jazieh AM, AlSumai TS, Ali YZ, et al. The pattern of bone involvement, management, and outcomes in patients with nonsmall cell lung cancer: A retrospective study[J]. Ann Thorac Med, 2018, 13(3): 150-155. doi: 10.4103/atm.ATM_385_17
|
| [3] |
Cianciosi D, Varela-Lopez A, Forbes-Hernandez TY, et al. Targeting molecular pathways in cancer stem cells by natural bioactive compounds[J]. Pharmacol Res, 2018, 135: 150-165. doi: 10.1016/j.phrs.2018.08.006
|
| [4] |
徐加英, 焦旸, 陈菊, 等.血根碱对人类宫颈癌细胞生长和转移的抑制作用[J].苏州大学学报(医学版), 2009, 29(5): 848-851. http://d.old.wanfangdata.com.cn/Periodical/szyxyxb200905012
Xu JY, Jiao Y, Chen J, et al. Effect of sanguinarine on proliferation and migration in human cervical cancer cells[J]. Suzhou Da Xue Xue Bao(Yi Xue Ban), 2009, 29(5): 848-851. http://d.old.wanfangdata.com.cn/Periodical/szyxyxb200905012
|
| [5] |
田龙夫, 张琦, 王波涛, 等.血根碱通过调控PI3K/Akt信号通路诱导胰腺癌细胞凋亡的机制[J].中国实验方剂学杂志, 2018, 24(19): 166-171. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zgsyfjxzz201819029
Tian LF, Zhang Q, Wang BT, et al. Mechanism of sanguinarine in inducing apoptosis in murine pancreatic cancer cells by inhibiting PI3K/Akt signaling pathway[J]. Zhongguo Shi Yan Fang Ji Xue Za Zhi, 2018, 24(19): 166-171. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zgsyfjxzz201819029
|
| [6] |
杨艺萱, 郭文静, 马承旭, 等.血根碱通过诱导活性氧促进HepG2细胞凋亡的机制研究[J].中国药理学通报, 2018, 34(3): 370-375. doi: 10.3969/j.issn.1001-1978.2018.03.015
Yang YX, Guo WJ, Ma CX, et al. Sanguinarine promotes apoptosis of Hep G2 cells by inducing ROS[J].Zhongguo Yao Li Xue Tong Bao, 2018, 34(3): 370-375. doi: 10.3969/j.issn.1001-1978.2018.03.015
|
| [7] |
Zhang R, Wang G, Zhang PF, et al. Sanguinarine inhibits growth and invasion of gastric cancer cells via regulation of the DUSP4/ERK pathway[J]. J Cell Mol Med, 2017, 21(6): 1117-1127. doi: 10.1111/jcmm.13043
|
| [8] |
Yang J, Fang Z, Wu J, et al. Construction and application of a lung cancer stem cell model: antitumor drug screening and molecular mechanism of the inhibitory effects of sanguinarine[J]. Tumour Biol, 2016, 37(10): 13871-13883. doi: 10.1007/s13277-016-5152-5
|
| [9] |
Rapp J, Jaromi L, Kvell K, et al. WNT signaling-lung cancer is no exception[J]. Respir Res, 2017, 18(1): 167. doi: 10.1186/s12931-017-0650-6
|
| [10] |
Kuttikrishnan S, Siveen KS, Prabhu KS, et al. Sanguinarine suppresses growth and induces apoptosis in childhood acute lymphoblastic leukemia[J]. Leuk Lymphoma, 2018: 1-13. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=10.1080/10428194.2018.1494270
|
| [11] |
路玉盼, 董宪喆, 冯霞, 等.血根碱抑制人乳腺癌细胞MCF-7增殖的机制研究[J].中国药理学通报, 2016, 32(6): 858-862. doi: 10.3969/j.issn.1001-1978.2016.06.023
Lu YP, Dong XZ, Feng X, et al. Sanguinarine inhibits cell proliferation in MCF-7 human mammary adenocarcinoma cells[J]. Zhongguo Yao Li Xue Tong Bao, 2016, 32(6): 858-862. doi: 10.3969/j.issn.1001-1978.2016.06.023
|
| [12] |
Wang Y, Zhang B, Liu W, et al. Noninvasive bioluminescence imaging of the dynamics of sanguinarine induced apoptosis via activation of reactive oxygen species[J]. Oncotarget, 2016, 7(16): 22355-22367. http://cn.bing.com/academic/profile?id=63ccb86bd522ed13b704994be84a6d81&encoded=0&v=paper_preview&mkt=zh-cn
|
| [13] |
Xu JY, Meng QH, Chong Y, et al. Sanguinarine is a novel VEGF inhibitor involved in the suppression of angiogenesis and cell migration[J]. Mol Clin Oncol, 2013, 1(2): 331-336. doi: 10.3892/mco.2012.41
|
| [14] |
Gu S, Yang XC, Xiang XY, et al. Sanguinarine-induced apoptosis in lung adenocarcinoma cells is dependent on reactive oxygen species production and endoplasmic reticulum stress[J]. Oncol Rep, 2015, 34(2): 913-919. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=2d8be40bbfd16c597c13c3c9b2f10595
|
| [15] |
Gatti L, Cossa G, Tinelli S, et al. Improved apoptotic cell death in drug-resistant non-small-cell lung cancer cells by tumor necrosis factor-related apoptosis-inducing ligand-based treatment[J]. J Pharmacol Exp Ther, 2014, 348(3): 360-371. doi: 10.1124/jpet.113.210054
|
| [16] |
Wei G, Xu Y, Peng T, et al. Sanguinarine exhibits antitumor activity via up-regulation of Fas-associated factor 1 in non-small cell lung cancer[J]. J Biochem Mol Toxicol, 2017, 31(8): 1021-1028. http://cn.bing.com/academic/profile?id=b67e65edaf0f54d980adf2c9705faf0a&encoded=0&v=paper_preview&mkt=zh-cn
|
| [17] |
Saeed MEM, Mahmoud N, Sugimoto Y, et al. Molecular Determinants of Sensitivity or Resistance of Cancer Cells Toward Sanguinarine[J]. Front Pharmacol, 2018, 9: 136-142. doi: 10.3389/fphar.2018.00136
|
| [18] |
张素仙, 王妍妍, 张琴, 等.血根碱对紫杉醇耐药卵巢癌A2780/Taxol细胞生长及TGF-β_1/Smad通路抑制的影响[J].中国中西医结合杂志, 2018, 38(6): 717-720.
Zhang SX, Wang YY, Zhang Q, et al. Sanguinarine Inhibited A2780/Taxol Cell Growth and TGF-beta1/Smad pathway in Paclitaxel Resistant Ovarian Cancer[J]. Zhongguo Zhong Xi Yi Jie He Za Zhi, 2018, 38(6): 717-720.
|
| [19] |
Ma Y, Yu W, Shrivastava A, et al. Sanguinarine inhibits pancreatic cancer stem cell characteristics by inducing oxidative stress and suppressing sonic hedgehog-Gli-Nanog pathway[J]. Carcinogenesis, 2017, 38(10): 1047-1056. doi: 10.1093/carcin/bgx070
|
| [20] |
McCubrey JA, Rakus D, Gizak A, et al. Effects of mutations in Wnt/beta-catenin, hedgehog, Notch and PI3K pathways on GSK-3 activity-Diverse effects on cell growth, metabolism and cancer[J]. Biochim Biophys Acta, 2016, 1863(12): 2942-2976. doi: 10.1016/j.bbamcr.2016.09.004
|
| [21] |
Yang K, Wang X, Zhang H, et al. The evolving roles of canonical WNT signaling in stem cells and tumorigenesis: implications in targeted cancer therapies[J]. Lab Invest, 2016, 96(2): 116-136. http://cn.bing.com/academic/profile?id=ca7c327bcb0b84a5323da5a7a9b7482c&encoded=0&v=paper_preview&mkt=zh-cn
|
| [22] |
Morris SL, Huang S. Crosstalk of the Wnt/beta-catenin pathway with other pathways in cancer cells[J]. Genes Dis, 2016, 3(1): 41-47. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=190810d8d49138097b732c25a5c5d32c
|
This work is licensed under a Creative Commons Attribution 3.0 License.
Copyright © Editorial Department of Cancer Prevention Research 鄂公网安备 42011102005013号 鄂ICP备2022015867号
Supported by: Beijing Renhe Information Technology Co., Ltd. 
DownLoad: